glp-1 intestine Receptor Agonists in Gastrointestinal Practices: Enhancing Both Procedural and Patient-Related Outcomes | SN Comprehensive Clinical Medicine function of glp 1 Emerging

There are many reasons that people stop these medications, including side effects, lack of medication availability, achievement of targeted weight loss, and insurance difficulties or inability to afford out-of-pocket costs

10.2337/db19-1830-P 110

While these two classes of antihyperglycemic medications work through similar pathways, their efficacy and side effect profiles differ, due to differences in the pharmacodynamic effect of DPP-4 inhibitors and GLP-1RAs with respect to enhancing GLP-1 activity

Pregnant and breastfeeding women should avoid the peptide due to unknown effects on fetal and infant development